Invention Grant
![Pyrazolo[1,5-A]pyrimidines for antiviral treatment](/docs/US/2016-01-19/US09238039B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrazolo[1,5-A]pyrimidines for antiviral treatment
- Patent Title (中): 吡唑并[1,5-A]嘧啶用于抗病毒治疗
-
Application No.: US13905410Application Date: 2013-05-30
-
Publication No.: US09238039B2Publication Date: 2016-01-19
- Inventor: Kerim Babaoglu , Constantine G. Boojamra , Eugene J. Eisenberg , Hon Chung Hui , Richard L. Mackman , Jay P. Parrish , Michael Sangi , Oliver L. Saunders , Dustin Siegel , David Sperandio , Hai Yang
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Agent Steven R. Eck
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; A61K31/55 ; A61K31/551 ; A61P11/00 ; A61K31/675 ; A61K45/06 ; A61K31/5377 ; C07D495/04 ; C07D513/04 ; C07F9/6561
![Pyrazolo[1,5-A]pyrimidines for antiviral treatment](/abs-image/US/2016/01/19/US09238039B2/abs.jpg.150x150.jpg)
Abstract:
The invention provides compounds of Formula I or Formula II: or a pharmaceutically acceptable salt or ester, thereof, as described herein. The compounds and compositions thereof are useful for treating Pneumovirinae virus infections. The compounds, compositions, and methods provided are particularly useful for the treatment of Human respiratory syncytial virus infections.
Public/Granted literature
- US20140154240A1 PYRAZOLO[1,5-A]PYRIMIDINES FOR ANTIVIRAL TREATMENT Public/Granted day:2014-06-05
Information query
